Medicare Enrolled
Dr. Jon Vu, DO
Pain Medicine · Flower Mound, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vu? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vu
Dr. Jon Vu is a pain medicine in Flower Mound, TX, with 18 years in practice. Based on federal Medicare data, Dr. Vu performed 8,075 Medicare services across 1,736 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vu received a total of $10,625 from 63 pharmaceutical and/or device companies across 587 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vu is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 6% volume in TX$ $10,625 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,075
Medicare services
Top 6% in TX for pain medicine
1,736
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~449 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) | 1,869 | $0 | $1 |
| Office visit, established patient (30-39 min) | 1,743 | $90 | $254 |
| Administration of psychological or neuropsychological test, first 30 minutes | 1,111 | $32 | $95 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 850 | $192 | $402 |
| Drug screening test | 849 | $61 | $162 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 235 | $7 | $22 |
| Anti-nausea injection (ondansetron/Zofran) | 176 | $0 | $5 |
| Contrast dye for imaging, lower concentration | 160 | $0 | $3 |
| Injection, midazolam hydrochloride, per 1 mg | 88 | $0 | $1 |
| Injection of additional new drug or substance into vein | 86 | $11 | $34 |
| Injection, methylprednisolone acetate, 80 mg | 85 | $9 | $25 |
| Joint injection, major joint | 73 | $55 | $174 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 72 | $34 | $99 |
| Injection, methylprednisolone acetate, 40 mg | 71 | $6 | $14 |
| Fluoroscopic guidance for needle placement | 70 | $82 | $180 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 46 | $44 | $139 |
| Injection of substance into lower spine canal using imaging guidance | 45 | $180 | $758 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 45 | $179 | $666 |
| Evaluation of neuropsychological test, first hour | 45 | $98 | $256 |
| Unclassified drugs | 44 | $1 | $47 |
| Injection of drug or substance into vein | 43 | $26 | $78 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 40 | $95 | $336 |
| Infusion, normal saline solution , 1000 cc | 38 | $2 | $21 |
| New patient office visit (45-59 min) | 26 | $121 | $379 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 25 | $189 | $782 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 25 | $105 | $392 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 25 | $484 | $1,745 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 24 | $138 | $446 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 24 | $268 | $755 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 23 | $210 | $513 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 19 | $256 | $1,053 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
36.2% medium
62.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,625
Total received (2018-2024)
Avg $1,518/year across 7 years
Top 24% in TX for pain medicine
63
Companies
587
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,598 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$27 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,095
2023$1,019
2022$750
2021$1,586
2020$844
2019$2,977
2018$2,353
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Nevro Corp.
$2,022
Collegium Pharmaceutical, Inc.
$1,480
Daiichi Sankyo Inc.
$908
Medtronic Vascular, Inc.
$617
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$471
Flexion Therapeutics, Inc.
$454
Abbott Laboratories
$399
Forte Bio-Pharma LLC
$394
PFIZER INC.
$299
Sentynl Therapeutics, Inc.
$237
Medtronic, Inc.
$216
Biohaven Pharmaceuticals, Inc.
$185
ARBOR PHARMACEUTICALS, INC.
$178
SI-BONE, INC.
$178
Indivior Inc.
$163
AbbVie Inc.
$145
BioDelivery Sciences International, Inc.
$145
Almatica Pharma LLC
$135
Takeda Pharmaceuticals U.S.A., Inc.
$126
Scilex Pharmaceuticals Inc.
$110
BOSTON SCIENTIFIC CORPORATION
$107
Biohaven Pharmaceutical Holding Company Ltd.
$103
Allergan, Inc.
$89
DePuy Synthes Sales Inc.
$78
ABBVIE INC.
$77
Medtronic USA, Inc.
$71
AstraZeneca Pharmaceuticals LP
$70
Arbor Pharmaceuticals, Inc.
$65
Neuronetics, Inc.
$64
Zyla Life Sciences, Inc.
$60
Virtus Pharmaceuticals LLC
$58
Boston Scientific Corporation
$55
INSYS Therapeutics Inc
$53
RedHill Biopharma Inc.
$48
Novartis Pharmaceuticals Corporation
$47
Valinor Pharma, LLC
$44
Avanos Medical
$43
Pacira Pharmaceuticals Incorporated
$41
Assertio Therapeutics, Inc.
$39
Purdue Pharma L.P.
$37
Shionogi Inc
$36
Vertical Pharmaceuticals, LLC
$36
FORTE BIO-PHARMA LLC
$34
SCILEX PHARMACEUTICALS INC.
$33
Horizon Therapeutics plc
$32
Azurity Pharmaceuticals, Inc.
$27
Pernix Therapeutics Holdings, Inc.
$26
ASSERTIO THERAPEUTICS, Inc.
$25
Kowa Pharmaceuticals America, Inc.
$25
Fidia Pharma USA Inc.
$24
Jazz Pharmaceuticals Inc.
$22
Siemens Medical Solutions USA, Inc.
$21
Curonix LLC
$20
Allergan Inc.
$18
US WorldMeds, LLC
$17
SI-BONE, Inc.
$16
Spinal Simplicity, LLC
$16
Stimwave Technologies Incorporated
$15
Becton, Dickinson and Company
$15
Orthogenrx Inc.
$14
Bioventus LLC
$14
Lilly USA, LLC
$13
Zyla Life Sciences
$13
Top 3 companies account for 41.5% of total payments
Associated products mentioned in payments ›
AIMOVIG · Amitiza · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · COOLIEF* COOLED RADIOFREQUENCY · Cambia · Cios Select · ClosureFast · DUEXIS · Durolane · EMGALITY · EPIDIOLEX · ETERNA · Evekeo · GRALISE · GenVisc 850 · Gralise · HA MINUTEMAN G3-R · HORIZANT · HYMOVIS · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · Iovera · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · LACTULOSE · LEVORPHANOL TARTRATE · LORZONE · LYRICA · Levorphanol · Levorphanol Tartrate · Lucemyra/Lofexidine · MONOVISC · MOVANTIK · Morphabond ER · Motegrity · Movantik · NALOCET · NAPRELAN · NEUROSTAR TMS THERAPY SYSTEM · NURTEC ODT · Nucynta · OCTRODE · Omnia · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PROLATE · Proclaim Family of SCS IPGs · Proclaim IPG · QULIPTA · RELISTOR · RELISTOR ORAL · SCS IPGs · SEGLENTIS · SPECTRA WAVEWRITER · SPRIX · SUBLOCADE · SUBSYS · SYMPROIC · SYNDROS · Seglentis · Senza · Senza II · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · Superion · Symproic · UBRELVY · V-LOC 180 · VANTA ADAPTIVESTIM · VECTRIS · VENASEAL · VenaSeal · Venclose Maven Catheter · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $132 per 100 Medicare services performed
Geographic Context
Pain Medicines within 10 mi
85
Per 100K population
9.0
County median income
$108,185
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL FLOWER MOUND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Vu is a clinical cardiology specialist, with above-average Medicare volume (top 6% in TX), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Vu experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Vu performed 1,869 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vu receive payments from pharmaceutical companies?
Yes. Dr. Vu received a total of $10,625 from 63 companies across 587 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vu's costs compare to other pain medicines in Flower Mound?
Dr. Vu's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Flower Mound
Browse pain medicines in Flower Mound ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in TX
Pain Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in TX
Which TX pain medicines receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp..
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc..
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology